Literature DB >> 1599293

Drug delivery from jet nebulisers.

M L Everard1, A R Clark, A D Milner.   

Abstract

Maximising the rate of drug delivered in particles small enough to reach the lower respiratory tract from jet nebulisers may allow treatment times to be reduced and thus improve the acceptability of this form of treatment, particularly in very young patients. The role of various technical factors such as driving gas flow (DGF) in determining the rate of drug delivery was studied by constructing a model to simulate the respiratory pattern of individuals with different tidal volumes using a Starling ventilator and filter. Sodium cromoglycate was nebulised under a variety of operating conditions and the dose deposited on the filter was assayed. Tidal volumes of 50 and 400 ml were used at a frequency of 32 breaths per minute. Increasing the DGF from 4 to 8 l/minute produced a 264% increase in the rate of drug output but only a 32% increase in aerosol concentration. The mass of drug contained within droplets less than 5 microns increased from 26.8% to 70.8% of the total. The resultant increase in rate of drug delivery to the filter was 34% for a tidal volume of 50 ml and 79% for a tidal volume of 400 ml though the dose contained within droplets less than 5 microns increased by 4-fold at 50 ml tidal volume and by more than 5-fold at the higher tidal volume. Halving the solution concentration halved the rate of drug delivery. Increasing the tidal volume 8-fold from 50 to 400 ml resulted in an increase in the rate of drug deposition upon the filter of only 2.2 to 3-fold depending upon the DGF so that substantially more drug per ml inhaled was delivered at the lower tidal volume. These results are explained by considering factors that influence the rate of drug delivery. At low tidal volumes the rate of drug delivery at a given respiratory rate is dependent on the tidal volume and aerosol concentration. At high tidal volumes it is dependent upon aerosol concentration and volume of available aerosol and is essentially independent of tidal volume.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599293      PMCID: PMC1793736          DOI: 10.1136/adc.67.5.586

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  The functional development of the respiratory system from the period of gestation to adulthood.

Authors:  G Polgar; T R Weng
Journal:  Am Rev Respir Dis       Date:  1979-09

2.  Evaluation of nebulisers for bronchial challenge tests.

Authors:  J N Tsanakas; A J Wilson; A W Boon
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

3.  Assessment of jet nebulisers for lung aerosol therapy.

Authors:  M M Clay; D Pavia; S P Newman; T Lennard-Jones; S W Clarke
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

4.  Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler.

Authors:  R A Lewis; J S Fleming
Journal:  Br J Dis Chest       Date:  1985-10

5.  Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.

Authors:  W Stahlhofen; J Gebhart; J Heyder
Journal:  Am Ind Hyg Assoc J       Date:  1980-06

6.  Quantitative deposition of aerosolized gentamicin in cystic fibrosis.

Authors:  J S Ilowite; J D Gorvoy; G C Smaldone
Journal:  Am Rev Respir Dis       Date:  1987-12

7.  Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.

Authors:  B M Zainudin; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1988-12       Impact factor: 9.139

8.  Dilution of nebulised aerosols by air entrainment in children.

Authors:  G G Collis; C H Cole; P N Le Souëf
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

9.  Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition.

Authors:  M A Johnson; S P Newman; R Bloom; N Talaee; S W Clarke
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

10.  Droplet size distributions of nebulised aerosols for inhalation therapy.

Authors:  S P Newman; P G Pellow; S W Clarke
Journal:  Clin Phys Physiol Meas       Date:  1986-05
View more
  27 in total

1.  Pectus excavatum: studiously ignored in the United Kingdom?

Authors:  R Wheeler; K Foote
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  How to choose delivery devices for asthma.

Authors:  C O'Callaghan; P W Barry
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

Review 3.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 4.  Maybe there is no such thing as bronchiolitis.

Authors:  Brian A Kuzik
Journal:  CMAJ       Date:  2016-02-01       Impact factor: 8.262

5.  Drug delivery from holding chambers with attached facemask.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 6.  Treatment of childhood asthma. Options and rationale for inhaled therapy.

Authors:  C V Powell; M L Everard
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

7.  Selecting and using nebuliser equipment.

Authors:  A H Kendrick; E C Smith; R S Wilson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 8.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

9.  Therapeutic aerosols in children.

Authors:  S H Thomas; S Batchelor; M J O'Doherty
Journal:  BMJ       Date:  1993-07-24

10.  Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!

Authors:  I Amirav; I Balanov; M Gorenberg; D Groshar; A S Luder
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.